Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 196

    1.

    "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.

    Savarino A, Mai A, Norelli S, El Daker S, Valente S, Rotili D, Altucci L, Palamara AT, Garaci E.

    Retrovirology. 2009 Jun 2;6:52.

    PMID:
    19486542
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

    Reuse S, Calao M, Kabeya K, Guiguen A, Gatot JS, Quivy V, Vanhulle C, Lamine A, Vaira D, Demonte D, Martinelli V, Veithen E, Cherrier T, Avettand V, Poutrel S, Piette J, de Launoit Y, Moutschen M, Burny A, Rouzioux C, De Wit S, Herbein G, Rohr O, Collette Y, Lambotte O, Clumeck N, Van Lint C.

    PLoS One. 2009 Jun 30;4(6):e6093.

    PMID:
    19564922
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors.

    Archin NM, Keedy KS, Espeseth A, Dang H, Hazuda DJ, Margolis DM.

    AIDS. 2009 Sep 10;23(14):1799-806.

    PMID:
    19590405
    [PubMed - indexed for MEDLINE]
    4.

    The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.

    Shehu-Xhilaga M, Rhodes D, Wightman F, Liu HB, Solomon A, Saleh S, Dear AE, Cameron PU, Lewin SR.

    AIDS. 2009 Sep 24;23(15):2047-50.

    PMID:
    19609198
    [PubMed - indexed for MEDLINE]
    5.

    Cell line-dependent variability in HIV activation employing DNMT inhibitors.

    Fernandez G, Zeichner SL.

    Virol J. 2010 Oct 13;7:266.

    PMID:
    20942961
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.

    Huber K, Doyon G, Plaks J, Fyne E, Mellors JW, Sluis-Cremer N.

    J Biol Chem. 2011 Jun 24;286(25):22211-8. Epub 2011 Apr 29.

    PMID:
    21531716
    [PubMed - indexed for MEDLINE]
    7.

    Histone deacetylase inhibitor Scriptaid reactivates latent HIV-1 promoter by inducing histone modification in in vitro latency cell lines.

    Ying H, Zhang Y, Lin S, Han Y, Zhu HZ.

    Int J Mol Med. 2010 Aug;26(2):265-72.

    PMID:
    20596607
    [PubMed - indexed for MEDLINE]
    8.

    Spectrum of cdk-9 inhibitor activity against HIV-1 replication among various models of chronic and latent infection.

    Pisell TL, Ho O, Lee G, Butera ST.

    Antivir Chem Chemother. 2001;12 Suppl 1:33-41.

    PMID:
    11594686
    [PubMed - indexed for MEDLINE]
    9.

    Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors.

    Ylisastigui L, Coull JJ, Rucker VC, Melander C, Bosch RJ, Brodie SJ, Corey L, Sodora DL, Dervan PB, Margolis DM.

    J Infect Dis. 2004 Oct 15;190(8):1429-37. Epub 2004 Sep 15.

    PMID:
    15378435
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.

    Lin S, Zhang Y, Ying H, Zhu H.

    Curr HIV Res. 2011 Jun;9(4):202-8. doi: 10.2174/157016211796320333.

    PMID:
    21631428
    [PubMed - indexed for MEDLINE]
    12.

    Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.

    Cucciolla V, Borriello A, Criscuolo M, Sinisi AA, Bencivenga D, Tramontano A, Scudieri AC, Oliva A, Zappia V, Della Ragione F.

    Carcinogenesis. 2008 Mar;29(3):560-7. Epub 2008 Jan 19.

    PMID:
    18204075
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies.

    Demonté D, Quivy V, Colette Y, Van Lint C.

    Biochem Pharmacol. 2004 Sep 15;68(6):1231-8. Review.

    PMID:
    15313421
    [PubMed - indexed for MEDLINE]
    14.

    Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1.

    Choi BS, Lee HS, Oh YT, Hyun YL, Ro S, Kim SS, Hong KJ.

    AIDS. 2010 Feb 20;24(4):609-11.

    PMID:
    20154582
    [PubMed - indexed for MEDLINE]
    15.

    Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors.

    Oguariri RM, Brann TW, Imamichi T.

    J Biol Chem. 2007 Feb 9;282(6):3594-604. Epub 2006 Dec 6.

    PMID:
    17150965
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Intracellular GSH content and HIV replication in human macrophages.

    Garaci E, Palamara AT, Ciriolo MR, D'Agostini C, Abdel-Latif MS, Aquaro S, Lafavia E, Rotilio G.

    J Leukoc Biol. 1997 Jul;62(1):54-9. Erratum in: J Leukoc Biol 2001 Aug;70(2):340. del-Latif MS [corrected to Abdel-Latif MS].

    PMID:
    9225993
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Histone deacetylase inhibitors and genomic instability.

    Eot-Houllier G, Fulcrand G, Magnaghi-Jaulin L, Jaulin C.

    Cancer Lett. 2009 Feb 18;274(2):169-76. Epub 2008 Jul 16. Review.

    PMID:
    18635312
    [PubMed - indexed for MEDLINE]
    18.

    Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.

    Van Lint C, Quivy V, Demonté D, Chariot A, Vanhulle C, de Walque S, Gaudray G, Veithen E, Bours V, Piette J, Burny A.

    Bull Mem Acad R Med Belg. 2004;159(Pt 2):176-89. Review.

    PMID:
    15615091
    [PubMed - indexed for MEDLINE]
    19.

    Novel indolocarbazole protein kinase C inhibitors prevent reactivation of HIV-1 in latently infected cells.

    Pätzold S, Schneider J, Rudolph C, Marmé D, Schächtele C.

    Antiviral Res. 1993 Dec;22(4):273-83.

    PMID:
    8279816
    [PubMed - indexed for MEDLINE]
    20.

    Inhibition of glutathione synthesis as a chemotherapeutic strategy for leishmaniasis.

    Kapoor P, Sachdev M, Madhubala R.

    Trop Med Int Health. 2000 Jun;5(6):438-42.

    PMID:
    10929144
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk